Post-transplant lymphoproliferative disease in children

Pediatric Transplantation

Volumn 5, Issue 4, 2001, Pages 250-257

  Collins, M H ^a,c   Montone, Kathleen T ^a   Leahey, Ann M ^a   Hodinka, Richard L ^b   Salhany, Kevin E ^a   Kramer, Deborah L ^a   Deng, C ^a   Tomaszewski, John E ^c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Epstein Barr virus; Lymphoma; Mortality; Pathology; Pediatric; Post transplant lymphoproliferative disease

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD MORTALITY; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IN SITU HYBRIDIZATION; INFANT; LYMPHOPROLIFERATIVE DISEASE; MALE; MORBIDITY; ORGAN TRANSPLANTATION; PEDIATRIC SURGERY; POSTOPERATIVE COMPLICATION; RISK FACTOR; SEROCONVERSION; SURVIVAL RATE; VIRUS INFECTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INFANT; LOGISTIC MODELS; LYMPHOPROLIFERATIVE DISORDERS; MALE; RNA, VIRAL; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME;

EID: 0034939004     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2001.005004250.x     Document Type: Article

References (35)

1. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between Epstein-Barr virus infection and immunosuppression
2. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders
3. Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation
4. In situ hybridization for Epstein-Barr virus NOT1 repeats in posttransplant lymphoproliferative disorder
5. Identification of Epstein-Barr virus lytic and latent RNA transcripts in post-transplant lymphoproliferative disorder
6. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disorder
7. Five years experience in renal transplantation with immunosuppressive drugs: Survival, function, complications and the role of lymphocyte depletion by thoracic duct fistula
8. Clinicopathologic features of posttransplant lymphoproliferative disorders
9. Epstein-Barr virus infections in children after transplantation of the small intestine
10. De novo malignancies in pediatric organ transplant recipients
11. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection
12. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation
13. Posttransplant lymphoproliferative disorder presenting in the head and neck
14. Malignant neoplasms following bone marrow transplantation
15. Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease
16. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: Disseminated disease of donor origin demonstrated by fluorescence in situ hybridization
17. Neoplastic disorders after pediatric heart transplantation
18. Significance of Epstein-Barr virus status and post-transplant lymphoproliferative disease in pediatric thoracic transplantation
19. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients
20. Malignancies in children with renal replacement therapy
21. Posttransplant lymphoproliferative disorder in pediatric renal transplantation
22. Malignancy and posttransplant lymphoproliferative disorder (PTLD) in pediatric renal transplant recipients: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)
23. Pediatric renal transplantation under tacrolimus-based immunosuppression
24. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestation in children
25. Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation
26. Post-transplant lymphoproliferative disorder
27. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency
28. Therapy for transplant related lymphoproliferative disease
29. Early identification of Epstein-Barr virus associated posttransplantation lymphoproliferative disease
30. Direct correlation between the load of Epstein-Barr virus infected lymphocytes in the peripheral blood of pediatric transplant patients and the risk of lymphoproliferative disease
31. Epstein-Barr virus polymerase chain reaction and serology in pediatric post-transplant lymphoproliferative disorder: Three year experience
32. Posttransplant lymphoproliferative disease in thoracic organ tranplant patients. Ten years of cyclosporine-based immunosuppression
33. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy
34. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednosine immunosuppression
35. Recurrent Epstein-Barr virus associated lesions in organ transplant recipients